Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-08

Clinical Trial Update: Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated a herbal combination of Passiflora incarnata, Crataegus oxyacantha, and Salix alba for mild to moderate anxiety and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Crataegus oxyacantha (Crataegus oxyacantha)
  • Passiflora incarnata (Passiflora incarnata)
  • Salix alba (Salix alba)

Snippet

Sponsor: Marjan Industria e Comercio ltda | Conditions: Anxiety Disorder | Phase 3 | Status: COMPLETED